The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Merck Sharp & Dome; Myriad Pharmaceuticals; NeraCare GmbH; Novartis
Travel, Accommodations, Expenses - Novartis
Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).
 
Gerald Fogarty
Employment - Genesis Cancer Care
Stock and Other Ownership Interests - Genesis Cancer Care
Consulting or Advisory Role - Merck Serono
Research Funding - Merck Serono
 
Kari Dolven-Jacobsen
Research Funding - Bristol-Myers Squibb (Inst)
 
Rachael L. Morton
No Relationships to Disclose
 
George Hruby
No Relationships to Disclose
 
Anna K. Nowak
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Douglas Pharmaceuticals; Douglas Pharmaceuticals; Epizyme; Merck Sharp & Dohme; Roche; Sellas Life Sciences; Trizell
Research Funding - AstraZeneca (Inst); Douglas Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim
 
Janette L. Vardy
No Relationships to Disclose
 
Katharine J. Drummond
No Relationships to Disclose
 
Haryana M. Dhillon
Honoraria - MSD Oncology
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - MSD
 
Catherine Mandel
No Relationships to Disclose
 
Richard A. Scolyer
No Relationships to Disclose
 
Brindha Shivalingham
No Relationships to Disclose
 
Mark R. Middleton
Honoraria - Amgen; Roche
Consulting or Advisory Role - BiolineRx; Bristol-Myers Squibb; CytomX Therapeutics; Immunocore; Johnson & Johnson; Merck; Newlink Genetics; Novartis; RigonTEC
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); RigonTEC (Inst); Roche (Inst); TC Biopharm (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Merck
 
Bryan H. Burmeister
Employment - Genesis Cancer Care
 
Serigne Lo
No Relationships to Disclose
 
Claudius H. Reisse
No Relationships to Disclose
 
Elizabeth J. Paton
No Relationships to Disclose
 
Victoria Steel
No Relationships to Disclose
 
Narelle C. Williams
No Relationships to Disclose
 
John F. Thompson
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD Australia; Provectus
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD Australia; Provectus
 
Angela M. Hong
Speakers' Bureau - Bristol-Myers Squibb